Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...
Vermont Business Magazine1d
UVMMC urges pediatric RSV immunization for newborns and infants
Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...
Managed Healthcare Executive1d
How Respiratory Microflora Shapes RSV Severity and Long-Term Asthma Risks in Children
The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Flu Cases Are Surging—Here’s Why This Season Is So Unusual
Flu cases are surging this winter—this season is no joke. New data from the Centers for Disease Control and Prevention ...
News Medical2d
AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials
AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
Arabian Post on MSN4d
AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.
Multiple Institutions Give AIM a “Buy” RatingHONG KONG SAR – Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its ...
Fact Check: Moderna began clinical trials of COVID vaccine in 2020, not 2017
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Zacks.com on MSN5d
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?
We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before ...
FiercePharma6d
Quantoom, DNA Script and EVA Pharma unite on Africa mRNA project
While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...
FiercePharma8d
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.”  | The company benefited from higher-than-expected sales of ...